News

Medical Device Network on MSN11h
Novocure’s device for metastatic NSCLC treatment gains CE Mark
The data from the Phase III LUNAR trial, which assessed the device’s treatment efficacy and safety, supported the approval.
CURE1d
Advocacy and ‘Radiating Valor’ Have a Transformative Impact
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
‘The Godfather of comedies’ now streaming for free will cure your Bank Holiday blues
On Google, Liana Schnabel wrote in a 5/5 review: ‘Was crying laughing! I don’t know how Steve Carell made his character the ...
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...
WAKE RADIOLOGY UNC HEALTH REX SUITS UP FOR PARTICIPATION IN 2025 SUSAN G. KOMEN® TRIANGLE RACE FOR THE CURE
Wake Radiology UNC Health Rex, the leading provider of outpatient medical imaging in the Triangle, is proud to announce its continued support for Susan G. Komen®, the world’s leading breast cancer ...